Bugworks Research, Inc.
Novel small-molecule antibiotics and antimicrobial therapies against resistant infectious diseases
- Sector
- Biotech
- Headquarters
- Saratoga, CA
- Founded
- 2014
- Latest Form D
- $6.8M, Mar 2024
- Total capital
- $39.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $39.1M
- 5 Form D · last Mar 2024
- 32 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 5
- first 2020
- Rank in peer group#269 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 5th filing$6.8M
- Private capital raisedForm D · SEC · 4th filing$16M
- Private capital raisedForm D · SEC · 3rd filing$6.2M
- Private capital raisedForm D · SEC · 2nd filing$8.5M
- Private capital raisedForm D · SEC · 1st filing$1.6M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#269 · top 19%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Anand AnandkumarExecutive Officer, DirectorNamed in SEC Form D filings
- Atsushi UsamiDirectorNamed in SEC Form D filings
- Atushi UsamiDirectorNamed in SEC Form D filings
- Bala SubramanianExecutive Officer, DirectorNamed in SEC Form D filings
- Pradeep FernandesExecutive OfficerNamed in SEC Form D filings
- Santanu DattaExecutive Officer, DirectorNamed in SEC Form D filings
Show all 8 people
- Tejasvi RaviDirectorNamed in SEC Form D filings
- Venkataraman SubramanianDirectorNamed in SEC Form D filings
What it has protected
USPTO · 5 granted of 5- GrantedDIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE Compounds As Adenosine 2A Receptor And Adenosine 2B Receptor AntagonistUSPTOUS 12,577,247
- GrantedOxazolidinone Antibiotic Compounds And Process Of PreparationUSPTOUS 11,590,142
- GrantedAnti-bacterial Heterocyclic Compounds And Their SynthesisUSPTOUS 11,401,277
Show all 5 patent records
- DIAMINOPYRAZOLO[1,5-A]PYRIMIDINE-6-CARBONITRILE Compounds As Adenosine 2A Receptor And Adenosine 2B Receptor AntagonistMar 17, 2026 · US 12,577,247Granted
- Oxazolidinone Antibiotic Compounds And Process Of PreparationFeb 28, 2023 · US 11,590,142Granted
- Anti-bacterial Heterocyclic Compounds And Their SynthesisAug 2, 2022 · US 11,401,277Granted
- Heterocyclic Compounds Useful As Anti-bacterial Agents And Method For Production ThereofFeb 9, 2021 · US 10,912,780Granted
- Substituted Oxazolidines As Anti-bacterial AgentsJul 14, 2020 · US 10,711,011Granted
Related companies, and why
- GLOBEIMMUNE INCSimilar federal contract value in Biotech · null in contracts
- Liquid BioScience, Inc.Similar federal contract value in Biotech · null in contracts
- Earli Inc.Similar federal contract value in Biotech · null in contracts
- Scholar RockSimilar federal contract value in Biotech · null in contracts
- SeaStar Medical, Inc.Similar federal contract value in Biotech · null in contracts
- SynthorxSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .